Isatuximab in Relapsed and/or Refractory AL Amyloidosis: Results of a Prospective Phase 2 Trial (SWOG S1702) Authors: Terri L. Parker, MD; Adam Rosenthal, MS; Vaishali Sanchorawala, MD; Heather J. Landau, MD; Erica L. Campagnaro, MD; Prashant Kapoor, MD; Natalia Neparidze, MD; Saulius Girnius, MD; Patrick Hagen, MD; Emma C. Scott, MD; Antje Hoering, PhD; Brian G. M. Durie, MD; Robert Z. Orlowski, MD, PhD

https://www.medscape.org/viewarticle/1003100?sso=true&impID=7893998&uac=148436CN&src=wnl_tpal_251121_mscpedu